Pyrrolopyrazine-Spirocyclic Piperidine Amides as Modulators of Ion Channels
Vertex Pharmaceuticals Incorporated
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 61/915,937, filed Dec 13, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,481,552 | Solid Forms of Gyrase Inhibitor (R)-1-Ethyl-3-[5-[2-(1-Hydroxy-1-Methyl-ETHYL)PYRIMIDIN-5-YL]-7-(TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL]UREA In force (reinstated) · High confidence UsedRemaining | Spero Therapeutics, Inc. | In force (reinstated) | High confidence | ||
| US 8,916,565 | Pyrrolopyrazine-Spirocyclic Piperidine Amides as Modulators of Ion Channels In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 9,511,067 | SUBSTITUTED SPIRO[PIPERIDINE-4,1'-Pyrrolo[1,2-a]PYRAZINE]S AS MODULATORS OF ION CHANNELS In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 9,181,273 | Morpholine-Spirocyclic Piperidine Amides as Modulators of Ion Channels In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 9,365,588 | Benzoxazines as Modulators of Ion Channels In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 10,385,070 | Chroman-Spirocyclic Piperidine Amides as Modulators of Ion Channels In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 9,403,839 | Pyran-Spirocyclic Piperidine Amides as Modulators of Ion Channels In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 9,108,903 | Amides as Modulators of Sodium Channels In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 9,421,196 | Amides as Modulators of Sodium Channels In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| US 10,233,191 | Fused Piperidine Amides as Modulators of Ion Channels In force · High confidence | Vertex Pharmaceuticals Incorporated | In force | High confidence | ||
| 16 more records in this group · Pro | ||||||
10 of 26 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 26, including 2 expired.
18 of these are in force and held by Vertex Pharmaceuticals Incorporated.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.